-

01:36:57 PM

USAQ Stock News

USAQ - QHSLab Inc

05/15/23 8:00 AM

OTC : USAQ

earningslow float

QHSLab, Inc. Reports First Quarter Financial Results

324% Sequential Revenue Growth in Q1 2023 Compared to Q4 2022 for its Digital Medicine Services. ● Total Q1 2023 revenue of $352,799 increased 32% over Q4 2022 revenue ● Expanded gross margin in Q1 2023 to 53% resulting in a 300-basis point increase in gross profit compared to the Q4 2022 ● Digital

RHEA-AI

positive

02/16/23 8:30 AM

OTC : USAQ

low float

QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida

QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, announces entry into a

RHEA-AI

very positive

01/30/23 8:30 AM

OTC : USAQ

low float

QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care

QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are currently witnessing poor outcomes from their previous investments. Multiple digital health companies

RHEA-AI

positive

11/14/22 8:30 AM

OTC : USAQ

low float

QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care

This forecast is based on estimates generated through a recent pilot program and scaled through approximately 250,000 independent primary care practitioners in the United States. ● National reports indicate that there are over 500 million healthcare patient encounters per year. 52% of all physician

RHEA-AI

positive

11/01/22 8:30 AM

OTC : USAQ

low float

QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force

The latest r ecommendations from the U.S. Preventive Services Task Force (U S PSTF) i ndicate that all adults under the age of 65 be screened for anxiety and depression in primary care including children and adolescents aged 8 to 18 years should also be regularly screened. ● The independent,

RHEA-AI

neutral

09/20/22 8:30 AM

OTC : USAQ

covid-19low float

QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians

Primary care physicians now have access to reimbursable digital tools for the routine assessment of post-COVID conditions Strengthening QHSLab’s Business Model and Expanding Digital Health Product Portfolio in the Large Primary Care Market Long COVID Digital Health Tool Focused on Primary Care

RHEA-AI

neutral

06/24/22 8:30 AM

OTC : USAQ

low float

QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services

QHSLab, Inc. (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare

RHEA-AI

positive

05/24/22 8:00 AM

OTC : USAQ

low float

QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance

QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point of care technologies, released the following letter to its

RHEA-AI

neutral

05/10/22 8:30 AM

OTC : USAQ

low float

New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT™.

QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging point of care technologies, projects a new $90 million annual addressable market for the

RHEA-AI

neutral

05/09/22 8:30 AM

OTC : USAQ

low float

QHSLab. Issues Update and Investor Presentation May 2022

Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio Addressable Market Opportunity Includes Over 250,000 Independent Primary Care Physicians Favorably Aligned with Industry Drivers Including Increasing Acceptance of

RHEA-AI

very positive